At the time, reports indicated that the team had no plans of trading George in the first year of his contract and had made that clear to him. However, according to NBA insider Sam Amico ...

The Philadelphia 76ers' decision to hand Paul George a four-year, $212 million deal in the summer was originally viewed as a masterstroke that would turn them into Championship contenders.

Their superstar acquisition, Paul George, has been a frequent name on the injury report and currently doesn’t have a timeline for a return in place. Soon, that could change. According to ESPN ...

KINGSTOWN, St. Vincent and the Grenadines, March 12, 2025 (GLOBE NEWSWIRE) -- WOO X, a leading global crypto trading platform, has introduced Demo Copy ... Markets Insider and Business Insider ...

George Demos, former vice president of drug safety and pharmacovigilance at Acadia Pharmaceuticals Inc., sold off more than 60,000 of his nearly 65,000 total option shares one day before the ...

George Demos, then-vice president at Acadia Pharmaceuticals, pleaded guilty to illegally selling 60,000 company shares, avoiding a $1.3 million loss by acting on insider knowledge about the labeling ...

George Demos, former vice president of drug safety and pharmacovigilance at Acadia Pharmaceuticals Inc., is the latest biopharma executive to plead guilty to insider trading charges. BioWorld ...

Eddie George, former Tennessee Titans running back, is leaving TSU to coach at Bowling Green. George coached the Tigers for four seasons, leading them to their first FCS playoff appearance since 2013.

The former vice president of a San Diego-based pharmaceutical company pleaded guilty today to a federal securities fraud count for insider trading. George Demos, 64, formerly of Acadia ...